The second half? It could well be a reference to the currently ongoing Vaxinia trial which is being done in combo with Keytruda. This would be more likely as it is actually in human trial and they are seeing results in Cohort 1 which has been completed.
I note that both YF and LC language confidence has been more buoyant recently. Surely it must be all those observation from both the Checkvacc and Vaxinia trials. And so far, both trials have run long enough and does not seems to have encountered any toxic or tolerability issue. So far, so good.
Media Thread, page-7191
-
- There are more pages in this discussion • 8,717 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.4¢ |
Change
0.001(1.16%) |
Mkt cap ! $323.5M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.3¢ | $246.0K | 5.704M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 1979441 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 2215701 | 16 |
View Market Depth
| Last trade - 11.18am 01/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |